206 related articles for article (PubMed ID: 25282593)
21. Evaluation of an ICD-10 algorithm to detect osteonecrosis of the jaw among cancer patients in the Danish National Registry of Patients.
Ehrenstein V; Gammelager H; Schiødt M; Nørholt SE; Neumann-Jensen B; Folkmar TB; Pedersen L; Svaerke C; Sørensen HT; Ma H; Acquavella J
Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):693-700. PubMed ID: 25974710
[TBL] [Abstract][Full Text] [Related]
22. Pathophysiology of Osteonecrosis of the Jaws.
Aghaloo T; Hazboun R; Tetradis S
Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):489-96. PubMed ID: 26412796
[TBL] [Abstract][Full Text] [Related]
23. Staging of osteonecrosis of the jaw requires computed tomography for accurate definition of the extent of bony disease.
Bedogni A; Fedele S; Bedogni G; Scoletta M; Favia G; Colella G; Agrillo A; Bettini G; Di Fede O; Oteri G; Fusco V; Gabriele M; Ottolenghi L; Valsecchi S; Porter S; Petruzzi M; Arduino P; D'Amato S; Ungari C; Fung Polly PL; Saia G; Campisi G
Br J Oral Maxillofac Surg; 2014 Sep; 52(7):603-8. PubMed ID: 24856927
[TBL] [Abstract][Full Text] [Related]
24. "Bis-phossy jaws" - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw.
Abu-Id MH; Warnke PH; Gottschalk J; Springer I; Wiltfang J; Acil Y; Russo PA; Kreusch T
J Craniomaxillofac Surg; 2008 Mar; 36(2):95-103. PubMed ID: 18234504
[TBL] [Abstract][Full Text] [Related]
25. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.
Boonyapakorn T; Schirmer I; Reichart PA; Sturm I; Massenkeil G
Oral Oncol; 2008 Sep; 44(9):857-69. PubMed ID: 18282788
[TBL] [Abstract][Full Text] [Related]
26. Standardized classification unsuitable for spontaneous reporting: the example of osteonecrosis of the jaw.
de Boissieu P; Trenque T
Expert Opin Drug Saf; 2015 Jul; 14(7):1015-21. PubMed ID: 25943856
[TBL] [Abstract][Full Text] [Related]
27. [Osteonecrosis of the jaws (ONJ) associated to antiresorptive treatment].
Larsson Wexell C; Kjellman A; Akre O
Lakartidningen; 2018 May; 115():. PubMed ID: 29809272
[TBL] [Abstract][Full Text] [Related]
28. Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients.
Voss PJ; Joshi Oshero J; Kovalova-Müller A; Veigel Merino EA; Sauerbier S; Al-Jamali J; Lemound J; Metzger MC; Schmelzeisen R
J Craniomaxillofac Surg; 2012 Dec; 40(8):719-25. PubMed ID: 22336489
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents.
Campisi G; Fedele S; Fusco V; Pizzo G; Di Fede O; Bedogni A
Future Oncol; 2014 Feb; 10(2):257-75. PubMed ID: 24490612
[TBL] [Abstract][Full Text] [Related]
30. Oral cutaneous sinus tract, vertical root fracture, and bisphosphonate-related osteonecrosis: a case report.
Wigler R; Steinbock N; Berg T
J Endod; 2013 Aug; 39(8):1088-90. PubMed ID: 23880284
[TBL] [Abstract][Full Text] [Related]
31. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
King AE; Umland EM
Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663
[TBL] [Abstract][Full Text] [Related]
32. Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients.
Favia G; Pilolli GP; Maiorano E
J Rheumatol; 2009 Dec; 36(12):2780-7. PubMed ID: 19884275
[TBL] [Abstract][Full Text] [Related]
33. [Bisphosphonate-associated osteonecrosis of the jaws in lung cancer patients].
Neves I; Morais A; Magalhães A
Rev Port Pneumol; 2013; 19(5):228-32. PubMed ID: 23830508
[TBL] [Abstract][Full Text] [Related]
34. The influence of alendronate and tooth extraction on the incidence of osteonecrosis of the jaw among osteoporotic subjects.
Chiu WY; Yang WS; Chien JY; Lee JJ; Tsai KS
PLoS One; 2018; 13(4):e0196419. PubMed ID: 29694412
[TBL] [Abstract][Full Text] [Related]
35. Osteonecrosis of the jaw onset times are based on the route of bisphosphonate therapy.
Fleisher KE; Jolly A; Venkata UD; Norman RG; Saxena D; Glickman RS
J Oral Maxillofac Surg; 2013 Mar; 71(3):513-9. PubMed ID: 22999296
[TBL] [Abstract][Full Text] [Related]
36. Bisphosphonate-associated osteonecrosis of the jaw: conclusions based on an analysis of case series.
Landesberg R; Wilson T; Grbic JT
Dent Today; 2006 Aug; 25(8):52, 54-7. PubMed ID: 16925161
[TBL] [Abstract][Full Text] [Related]
37. CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part II: a prospective clinical study.
Lee CY; Suzuki JB
Implant Dent; 2010 Feb; 19(1):29-38. PubMed ID: 20147814
[TBL] [Abstract][Full Text] [Related]
38. The risk of osteonecrosis of the jaws in Taiwanese osteoporotic patients treated with oral alendronate or raloxifene.
Chiu WY; Chien JY; Yang WS; Juang JM; Lee JJ; Tsai KS
J Clin Endocrinol Metab; 2014 Aug; 99(8):2729-35. PubMed ID: 24758181
[TBL] [Abstract][Full Text] [Related]
39. Antiresorptives and osteonecrosis of the jaw.
Yamashita J; McCauley LK
J Evid Based Dent Pract; 2012 Sep; 12(3 Suppl):233-47. PubMed ID: 23040351
[TBL] [Abstract][Full Text] [Related]
40. [Bisphosphonates and osteonecrosis of the jaws].
Urade M
Clin Calcium; 2007 Feb; 17(2):241-8. PubMed ID: 17272882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
